Expression patterns of proteins involved in serine and glycine metabolism, and correlations of these patterns with clinicopathologic factors in phyllodes tumor were investigated. Tissue microarrays were prepared from 203 phyllodes tumors (PT) and stained with antibodies specific for glycine decarboxylase (GLDC), phosphoserine aminotransferase 1 (PSAT1), phosphoserine phosphatase (PSPH), phosphoglycerate dehydrogenase (PHGDH), and serine hydroxymethyltransferase 1 (SHMT1). These immunohistochemical results and clinicopathologic parameters were analyzed for correlation. Numbers of benign, borderline, and malignant tumors were 155, 32, and 16, respectively. Stromal expression of PHGDH, PSAT1, PSPH, SHMT1, and GLDC increased with increasing tumor grade, and epithelial expression of SHMT1 also increased with increasing tumor grade (p<0.001, and p=0.005, respectively). On univariate analysis, positive stainings for stromal PHGDH (p<0.001), stromal PSAT1 (p<0.001), stromal PSPH (p=0.003), epithelial SHMT1 (p=0.001), stromal SHMT1 (p=0.022), and stromal GLDC (p<0.001) were each associated with shorter disease-free survival. Stromal GLDC was associated with shorter overall survival (p<0.001). In conclusion, expression of proteins related to serine and glycine metabolism increased with increasing histologic grade in stromal components of phyllodes tumor.
Unlike normal cells, which oxidize glucose through the tricarboxylic acid (TCA) cycle and mitochondrial electron transport, cancer cells may shift into glycolysis despite presence of adequate oxygen. This shift, known as the 'Warburg effect' [1] , results in accumulation of glycolytic intermediates and patterns of gene activation that may promote tumor growth. The interconnections of pathways for serine and glycine biosynthesis reveal various levels at which a shift to anerobic metabolism could support cell proliferation [2] [3] [4] [5] . In serine biosynthesis, 3-phosphoglycerate (3PG) produced in glycolysis is oxidized by phosphoglycerate dehydrogenase (PHGDH) to 3-phosphohydroxypyruvate (pPYR), which in turn is transaminated by phosphoserine aminotransferase (PSAT) into phosphoserine (pSER), which is dephosphorylated by phosphoserine phosphatase (PSPH) into serine. In glycine metabolism, glycine decarboxylase (GLDC) catalyzes the catabolism of the glycine into methylene-tetrahydrofolate (MTF). The interconversion of serine and glycine by serine hydroxymethyltransferase (SHMT) represents a crossover point from which single carbon units flow from amino acid turnover into the synthesis of purines and pyrimidines (by way of 5, 10-methylenetetrahydrofolate and 5-methyltetrahydrofolate) and into the essential amino acid methionine and the universal methyl-donor S-adenosylmethionine (SAM), by way of 5-MTHF. Increased availability of these substrates for growth may in part explain the advantage to the tumor in the shift to anaerobic metabolism. Recent studies show elevated PHGDH expression in breast cancer and melanoma [3, 4] , and GLDC expression in lung cancer, suggesting that changes in serine and glycine metabolism may influence tumorigenesis [5] .
Although phyllodes tumors (PTs) contribute only 0.3-1.5% of all breast neoplasms, they may be difficult to distinguish from fibroadenomas, which belong to the same class of fibroepithelial tumors. Both tumors present heterogeneous histologic features, however, some histologic features of the two tumors overlap [6, 7] . In addition, some PTs exhibit malignant behaviors such as occasional recurrence and hematogenous metastasis [8] . Although authors disagree on the histologic classification of PTs, the WHO criteria distinguish PTs as benign, borderline, or malignant tumors [7] . With increasing grade, the frequency of recurrence and/or probability of distant metastasis of PTs also increase. We showed previ-ously that expression of the glycolysis-related proteins such as Glut-1, CAIX, and MCT4 in PTs increases with increasing tumor grade [9] . We conducted the present study to investigate the expression of proteins related to serine and glycine metabolism, and to correlate these expressions with clinical and pathologic features of PT.
Patients and methods
Patient selection. Tissue samples were obtained from phyllodes tumors (PTs) removed during surgeries performed in the years 2000 to 2010, and prepared and archived at the Department of Pathology at Severance Hospital. All tis- sues were fixed in 10% buffered formalin and embedded in paraffin prior to staining with hematoxylin and eosin (H&E). Two pathologists (JS Koo and W Jung) reviewed all of the archived H&E slides. The PTs were graded according to criteria in the World Health Organization Classification of Tumors 2003 [7] . Clinical factors assessed were patient age, tumor recurrence, distant metastasis, and survival. The Institutional Review Board of Yonsei University Severance Hospital approved the study.
Tissue microarray (TMA). A representative area was selected fom each H&E-stained slide and a corresponding spot was marked on the surface of the paraffin block. Using a biopsy needle, the selected area was punched out and the 5-mm tissue core was placed in a 5 x 6 recipient block. Two tissue cores were extracted to minimize extraction bias. Each separate tissue core was assigned a unique tissue microarray location number that was linked to a database including other clinical-pathologic data.
Immunohistochemistry. The antibodies used for immunohistochemistry in this study are shown in Table 1 . All immunostainings were performed using formalin-fixed, paraffin-embedded tissue sections. Briefly, sections 5 μm thick were obtained with a microtome, transferred into adhesive slides, and dried at 62 °C for 30 min. After incubation with primary antibodies, immunodetection was performed with biotinylated antimouse immunoglobulin, followed by peroxidase-labeled streptavidin using a labeled streptavidin biotin kit with 3,3´-diaminobenzidine chromogen as substrate. The primary antibody incubation step was omitted in the negative control. Slides were counterstained with Harris *Eighteen cases without an epithelial component were excluded. † P-values are corrected for multiple testing using the Bonferroni correction. HPF, high-powered fields; Enzyme abbreviations as in Table 1 hematoxylin. Immunohistochemical markers for GLDC, PSAT, PSPH, PHGDH, and SHMT1 were assessed by light microscopy. The staining results were semi-quantitatively scored by multiplying the proportion of stained cells by immunostaining intensity. The proportion of cells stained was categorized as 0 (negative), 1 (< 30% of tumor cells), or 2 (> 30% of tumor cells), and the intensity was categorized as 0 (negative), 1 (weak), 2 (moderate), or 3 (strong). The total score was determined as negative (0 to 1) or positive (2 to 6) [10] . Ki-67 labeling indices (LI) were scored by counting the number of positively stained nuclei and is expressed as a percentage of total tumor cells.
Statistical analysis. Data were analyzed using SPSS for Windows, Version 12.0 (SPSS Inc., Chicago, IL, USA). For determination of statistical significance, Student's t and Fisher's exact tests were used for continuous and categorical variables, respectively. A p-value less than 0.05 was considered significant. Time to tumor recurrence was evaluated using Kaplan-Meier survival curves and the log-rank test. Multivariate regression analysis was performed using Cox proportional hazards model.
Results
Basal characteristics of phyllodes tumor. Table 2 shows basal characteristics of 203 patients with PTs that included 155 (76.4%) benign, 32 (15.8%) borderline, and 16 (7.9%) malignant tumors. Higher tumor grade was associated with patient age (p=0.010), tumor size (p=<0.001), tumor recurrence (p<0.001), and distant metastasis (p<0.001). Eight patients developed distant metastasis, exclusively to the lung. Expression of proteins related to serine and glycine metabolism according to phyllodes tumor grade. The immunohistochemical analysis of TMA revealed that stromal expression of PHGDH, PSAT1, PSPH, SHMT1, and GLDC (p<0.001, Figure 1 ) and epithelial expression of SHMT1 (p=0.005) were associated with increasing histologic grade (Table 3) . Additionally, we evaluated the association between expression of serine/glycine metabolism-related proteins and Ki-67 LI. Epithelial expression of PHGDH and PSPH was positively correlated with Ki-67 LI of epithelial component * P-values are corrected for multiple testing using the Bonferroni correction. HPF, high-powered fields; Abbreviations as in Table 1 (p=0.019, and 0.005, respectively), and stromal expression of PHGDH (p<0.001), PSAT1 (p<0.001), SHMT1 (p=0.002) and GLDC (p<0.01) was positively correlated with Ki-67 LI of stromal component (Table 4) .
Correlations between serine and glycine-related proteins expressed in phyllodes tumor and pathologic parameters. In this set of patients with PT, PHGDH expression in epithelial component was correlated with infiltrative tumor margin (p=0.045), and SHMT1 expression in epithelial component was correlated with increased stromal atypia (p=0.005), increased stromal mitosis (p=0.010), and tumor recurrence (p=0.015) ( Table 5) .
In stromal regions of these PTs, expression of PHGDH, PSAT1, PSPH, SHMT1, and GLDC were all correlated with increased stromal cellularity, increased stromal atypia, increased mitosis, stromal overgrowth, and infiltrative tumor margin (p<0.05). In addition, PHGDH, PSAT1, PSPH, and GLDC expressions were correlated with tumor recurrence and distant metastasis (p<0.05, Table 6 ).
Correlations between serine and glycine-related and glycolysis-related proteins expressed in PT. Previously we reported on expression of glycolysis-related proteins Glut-1, CAIX, and MCT4 [9] . In this study, we investigated associations between expression of Glut-1, CAIX, and MCT4 and expression of proteins involved in serine and glycine metabolism. In epithelial portions of the tumors we found no correlations (Table 7) . Within stromal regions, MCT4 expression was correlated with stromal PHGDH (p<0.001), stromal PSAT1 (p<0.001), stromal PSPH (p<0.001), stromal SHMT1 (p<0.001), and stromal GLDC (p=0.006) expression. In addition, stromal CAIX expression correlated with stromal SHMT1 and stromal GLDC expression (p<0.001, Table 8 ).
Associations of serine and glycine-related protein expression with patient outcome in PT. In univariate analysis, positive staining for stromal PHGDH (p<0.001), stromal PSAT1 (p<0.001), stromal PSPH (p=0.003), epithelial SHMT1 (p=0.001), stromal SHMT1 (p=0.022), and stromal GLDC (p<0.001) in the PT were associated with shorter disease-free survival (DFS) ( Table 9 ). Positive staining for stromal GLDC in the PT was associated with shorter overall survival (OS) (p<0.001, Figure 4) . Multivariate Cox analysis revealed no factor independently associated with shorter DFS or shorter OS (Table 10) .
Discussion
A principal finding in this study was that stromal expression of proteins related to serine and glycine metabolism increased in phyllodes tumors with increasing histologic tumor grade. Although we found no previous study appropriate for comparison, reported associations of PHGDH with breast carcinoma [4] and melanoma [3] , and of GLDC with tumor aggressiveness in pulmonary non-small cell carcinoma [5] , are compatible with our results. In a previous study we found that stromal expression of the glycolysis-related proteins * P-values are corrected for multiple testing using the Bonferroni correction. E, epithelial; S, stromal, Glut1, glucose transporter 1; CAIX, carbonic anhydrase; MTC4, monocarboxylate transporter 4; other enzymes as in Table 1 glucose transporter-1 (Glut-1), carbonic anhydrase (CAIX), and monocarboxylate transporter 4 (MCT4) increased with increasing tumor grade in PT [9] , consistent with an increase in demand for energy and anabolic substrates. Results in the present study confirmed a similar increase in serine and glycine metabolism with tumor grade. In addition, we observed an association between glycolysis-related proteins and proteins related to serine and glycine metabolism, consistent with the interdependence of these pathways. Specifically, expression of the glycolysis-related proteins CAIX and MCT4 in stromal regions of PT were significantly correlated with stromal expression of proteins related to serine and glycine metabolism. A previous study suggested that increased biosynthesis of serine influences breast cancer behavior through production of α-ketoglutarate, a TCA cycle intermediate, rather
than by other conversions of serine [4] . This may result in suggestion that the increased glycolysis and increased serine metabolism that we observed in phyllodes tumor, as products of these pathways feed into mitochondrial metabolism. Studies on the expression of ATP synthase, glutaminase 1 (GLS1) and succinate dehydrogenase (SDH) may resolve this question.
In this study, increased stromal expression of SHMT1 in PT with increasing histologic grade is consistent with a role for glycine in rapid cancer cell proliferation as previously reported [2] . In the epithelial component of PT, only SHMT1 among serine/glycine metabolism-related proteins showed increased expression with increasing tumor grade. Although malignant PTs may occasionally display vigorous stromal proliferation resulting in no identifiable epithelial component, epithelial proliferation, when present, is more often observed in borderline PTs than in benign ones, suggesting that singlecarbon metabolism may influence progression in the epithelial component of PT. The GLDC expression also increased with increasing histologic grade in this set of phyllodes tumors. The exact mechanism for this is unknown; however, it may possibly be explained as a secondary effect of oncogene overexpression. The expression of GLDC is shown to increase in cultured breast epithelial cells following transformation by KRAS, PIK3CA and MYC oncogenes (MCF10A) [5] , and stromal c-myc [11] and EGFR [12] expression may increase with increasing histologic grade in PTs.
Our results demonstrating the significant association between stromal expression of serine/glycine metabolism-related proteins of PT and poor prognosis are consistent with the results of previous studies; PHGDH expression and GLDC expression were reported to be correlated with poor prognosis in cervical cancer [13] and lung cancer [5] , respectively. Expression of glycolysis-related proteins such as Glut-1 [14, 15] , CAIX [16, 17] , MCT-4 [18] [19] [20] [21] was reported to be associated with poor prognosis in various type of cancer, indicating that increased glycolysisrelated metabolism has a correlation with poor prognosis.
Based on the roles of serine and glycine in single-carbon metabolism, increased stromal expression of enzymes that metabolize these amino acids with increasing histologic grade in PTs may have therapeutic significance. Ongoing preclinical studies of drugs targeting multiple sites of one-carbon metabolism, including GLDC, PSAT, PSPH, PHGDH, may yield new possibilities for the therapy of PTs [14, 22] .
In conclusion, expression of proteins related to serine and glycine metabolism increased in the stromal component of phyllodes tumor with increasing tumor histologic grade, and expression of these proteins correlated with expression of the glycolysis-related proteins CAIX, and MCT4. Abbreviations: HPFs, high-power fields; S, stromal component; E, epithelial component; enzymes as in Table 1 .
